Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major

Abstract

The early use of deferoxamine in an amount proportional to the transfusional iron load reduces the body iron burden and helps protect against diabetes mellitus, cardiac disease, and early death in patients with thalassemia major.